
Cyclana Bio raises £5 million to develop endometriosis treatment
Biotechnology company Cyclana Bio has raised £5 million ($6.7 million) to advance its drug discovery for endometriosis. The pre-seed funding round was co-led by NfX and Eka VC, with investors including Cocoa VC, Wilbe, and Angel investors. Cyclana Bio aims to use the investment to develop both functional disease models… Read More














